Trial Profile
Effect of bivalirudin +platelet glycoprotein IIbIIIa inhibitors versus heparin + platelet glycoprotein IIbIIIa inhibitors in patients from hospitals in michigan undergoing primary percutaneous coronary intervention
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Jun 2015
Price :
$35
*
At a glance
- Drugs Bivalirudin (Primary) ; Heparin; Platelet glycoprotein GPIIb IIIa complex inhibitors
- Indications Haemorrhage; Thrombosis
- Focus Therapeutic Use
- 15 Jun 2015 New trial record